Results 151 to 160 of about 192 (165)

Insulin: an endogenous cardioprotector

Current Opinion in Critical Care, 2003
This review discusses the myocardial protective property of the insulin/glucose-insulin-potassium regimen and the mechanisms involved in this beneficial action. Several recent studies suggest that insulin not only is useful to control hyperglycemia and maintain glucose homeostasis but also may have the unique property to protect the myocardium from ...
openaire   +2 more sources

The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

Cancer Chemotherapy and Pharmacology, 2003
Monohydroxyethylrutoside (monoHER) has proved to be a good protector against doxorubicin-induced cardiotoxicity without interfering with the antitumor effect of doxorubicin. The aim of the present study was to determine whether there is a pharmacokinetic interaction between monoHER and doxorubicin which may be involved in monoHER cardioprotection.Mice ...
Abou el Hassan, M.A., Kedde, M.A., Zwiers, U.T., Bast, A., van der Vijgh, W.J.F.   +4 more
openaire   +3 more sources

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

JNCI Journal of the National Cancer Institute, 1992
Although doxorubicin is an anticancer agent with a wide spectrum of activity, therapy with this anthracycline must often be discontinued at a time of benefit to the patient because of the drug's cumulative cardiotoxicity. ICRF-187 (ADR-529, dexrazoxane) is a bisdioxopiperazine compound that protects against cardiac toxicity induced by doxorubicin.Our ...
H, Hochster, L, Liebes, S, Wadler, R, Oratz, J C, Wernz, M, Meyers, M, Green, R H, Blum, J L, Speyer   +8 more
openaire   +2 more sources

[Na+/H+ exchange inhibitors: a new class of cardioprotectors].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2005
The Na+/H+ exchanger (NHE) extrudes intracellular H+ in exchange for Na+ in an electroneutral process. Of the 6 mammalian exchanger isoforms identified to date, the NHE-1 is believed to be the molecular homologue of the sarcolemma Na+/H+ transporter. The exchanger is activated primarily by a reduction in intracellular pH, although such activation is ...
openaire   +1 more source

Adenosine, the natural cardioprotector?

Journal of Molecular and Cellular Cardiology, 1990
openaire   +1 more source

Papel cardioprotector del aceite de oliva virgen extra

2017
Grado en Nutrición Humana y ...
openaire   +1 more source

Levosimendan in viral myocarditis: not only an inodilator but also a cardioprotector?

European Journal of Clinical Investigation, 2009
J T, Parissis, G, Filippatos
openaire   +2 more sources

Efecto cardioprotector del bloqueador beta de acción ultracorta esmolol en isquemia/reperfusión experimental

Revista Española de Cardiología, 2022
Jorge Nuche, Sergio Huertas, Carlos Galán-Arriola, Pedro López-Ayala, Manuel Lobo, Borja Ibáñez   +5 more
openaire   +1 more source

[Cardioxan as a cardioprotector in antineoplastic chemotherapy].

Klinicheskaia meditsina, 1997
M P, Lichinitser, G V, Vyshinskaia, E D, Min'kov, T A, Nakhalova, A A, Odzharova, A M, Garin   +5 more
openaire   +1 more source

Cardioprotectoral Influence of Metabolitotropic Measures in Physical Loading of Intact Rats and on the Coronary Vasospasm

Ukraïnsʹkij žurnal medicini, bìologìï ta sportu, 2018
N. A. Gorchakova, E. A. Nagornaya, I. F. Belenichev, I. S. Chekman   +3 more
openaire   +1 more source